Merlin, Inc. filed an 8-K on November 19, 2026, disclosing that Matthew George transitioned out of his roles as Chief Executive Officer, Chairman, and Board member effective November 18, 2026, with Dr. Robert H. Smith appointed as Interim Chief Executive Officer and Chairman of the Board on the same date.

Key Highlights

  • CEO transition: Matthew George moved from Chief Executive Officer and Chairman to the role of Founder and Advisor, effective November 18, 2026.
  • Interim CEO appointed: Dr. Robert H. Smith, age 62 and a Board member since March 16, 2026, was appointed Interim Chief Executive Officer and Chairman of the Board.
  • Interim CEO compensation: Dr. Smith will receive a monthly salary of $48,000, prorated for partial months, plus a restricted stock unit award for 500,000 shares tied to his Interim CEO tenure.
  • George severance terms: Mr. George will receive a cash payment equal to one and one-half times his current base salary, paid in eighteen monthly installments, plus an annual bonus based on target performance and eighteen months of subsidized health insurance.
  • Advisor fee: As Founder and Advisor, Mr. George will receive a monthly consulting fee of $6,250, prorated for partial months, for up to one year from the Effective Date.
  • CEO search launched: According to the filing, the Board "is commencing a search for a permanent CEO and will consider both internal and external candidates."
  • Emerging growth company: Merlin, Inc. is designated as an emerging growth company under the applicable SEC rules.

Leadership Change at Merlin: George's Departure Terms and Smith's Appointment

According to the filing, Mr. George's departure from the Chief Executive Officer and Chairman roles constitutes a resignation for "Good Reason" under the Company's Executive Severance Plan. The Transition Agreement, entered into on November 18, 2026, governs the terms of his new Founder and Advisor role and the severance payments owed to him. His advisory engagement runs until the first anniversary of the Effective Date unless earlier terminated by Mr. George for any reason or by the Company for cause.

The filing discloses that Mr. George's outstanding options and time-based restricted stock unit awards will continue to vest while he serves as Founder and Advisor. Upon termination of that service for reasons other than cause or early resignation before the first anniversary, all unvested awards will become fully vested. The Transition Agreement also includes non-compete, non-solicitation, and non-interference restrictions for the duration of his advisory service, as well as a standstill agreement for three years following the Effective Date. All payments and benefits are conditioned on Mr. George's execution and non-revocation of a release of claims in favor of the Company, the filing stated.

Dr. Smith brings a career that includes serving as Chief Executive Officer of Blue Origin from September 2017 until January 2024, followed by his current roles as Principal at Right Hand Side and Co-Founder at JATO Foundation since January 2024, as well as Senior Advisor to the Office of the Secretary of Defense under the Business Operators for National Defense (BOND) program, according to the filing. His initial term as Interim CEO is six months, subject to extension for successive three-month periods on mutual agreement. The filing states there are no arrangements or understandings between Dr. Smith and any person other than directors or officers of the Company acting in those capacities, no family relationships with other directors or executive officers, and no material interest in any transaction requiring disclosure under Item 404(a) of Regulation S-K.

What Was Disclosed

Merlin, Inc. (NASDAQ:MRLN) reported a CEO and Chairman transition effective November 18, 2026, detailing the severance and advisory terms for outgoing CEO Matthew George and the compensation package for incoming Interim CEO Dr. Robert H. Smith, while disclosing a permanent CEO search is underway.